Amonafide L-Malate (AS1413) in Combination with Cytarabine Is Equally Effective in Older and Younger Patients with Secondary Acute Myeloid Leukemia (AML); Final Data From a Phase II Study.
Publication
, Conference
Erba, HP; O'Donnell, M; Allen, SL; Baer, MR; Powell, BL; Stone, RM; Bennett, JM; Lundberg, AS; Capizzi, RL; Rizzieri, DA
Published in: Blood
November 20, 2009
Duke Scholars
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 20, 2009
Volume
114
Issue
22
Start / End Page
1047 / 1047
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Erba, H. P., O’Donnell, M., Allen, S. L., Baer, M. R., Powell, B. L., Stone, R. M., … Rizzieri, D. A. (2009). Amonafide L-Malate (AS1413) in Combination with Cytarabine Is Equally Effective in Older and Younger Patients with Secondary Acute Myeloid Leukemia (AML); Final Data From a Phase II Study. In Blood (Vol. 114, pp. 1047–1047). American Society of Hematology. https://doi.org/10.1182/blood.v114.22.1047.1047
Erba, Harry P., Margaret O’Donnell, Steven L. Allen, Maria R. Baer, Bayard L. Powell, Richard M. Stone, John M. Bennett, Ante S. Lundberg, Robert L. Capizzi, and David A. Rizzieri. “Amonafide L-Malate (AS1413) in Combination with Cytarabine Is Equally Effective in Older and Younger Patients with Secondary Acute Myeloid Leukemia (AML); Final Data From a Phase II Study.” In Blood, 114:1047–1047. American Society of Hematology, 2009. https://doi.org/10.1182/blood.v114.22.1047.1047.
Erba HP, O’Donnell M, Allen SL, Baer MR, Powell BL, Stone RM, et al. Amonafide L-Malate (AS1413) in Combination with Cytarabine Is Equally Effective in Older and Younger Patients with Secondary Acute Myeloid Leukemia (AML); Final Data From a Phase II Study. In: Blood. American Society of Hematology; 2009. p. 1047–1047.
Erba, Harry P., et al. “Amonafide L-Malate (AS1413) in Combination with Cytarabine Is Equally Effective in Older and Younger Patients with Secondary Acute Myeloid Leukemia (AML); Final Data From a Phase II Study.” Blood, vol. 114, no. 22, American Society of Hematology, 2009, pp. 1047–1047. Crossref, doi:10.1182/blood.v114.22.1047.1047.
Erba HP, O’Donnell M, Allen SL, Baer MR, Powell BL, Stone RM, Bennett JM, Lundberg AS, Capizzi RL, Rizzieri DA. Amonafide L-Malate (AS1413) in Combination with Cytarabine Is Equally Effective in Older and Younger Patients with Secondary Acute Myeloid Leukemia (AML); Final Data From a Phase II Study. Blood. American Society of Hematology; 2009. p. 1047–1047.
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 20, 2009
Volume
114
Issue
22
Start / End Page
1047 / 1047
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology